Moving forward with actionable therapeutic targets and opportunities in endometrial cancer: A NCI clinical trials planning meeting report.

Lheureux, Stephanie; McCourt, Carolyn; Rimel, B J; Duska, Linda; Fleming, Gini; Mackay, Helen; Mutch, David; Temkin, Sarah M; Lynn, Jean; Kohn, Elise C

Lheureux, Stephanie; McCourt, Carolyn; Rimel, B J; Duska, Linda; Fleming, Gini; Mackay, Helen; Mutch, David; Temkin, Sarah M; Lynn, Jean; Kohn, Elise C.

Afiliación

Lheureux S; Princess Margaret Cancer Centre, Toronto, Canada.
McCourt C; Washington University St. Louis, MO, United States.
Rimel BJ; Cedars Sinai Cancer Center, Los Angeles, CA, United States.
Duska L; University of Virginia, Charlottesville, VA, United States.
Fleming G; University of Chicago, Chicago, IL, United States.
Mackay H; University of Toronto, Sunnybrook, Toronto, Canada.
Mutch D; Washington University St. Louis, MO, United States.
Temkin SM; Virginia Commonwealth University, Richmond, VA, United States.
Lynn J; Coordinating Center for Clinical Trials, National Cancer Institute, Bethesda, MD, United States.
Kohn EC; Cancer Therapy Evaluation Program, National Cancer Institute, Bethesda, MD, United States. Electronic address: kohne@mail.nih.gov.

Gynecol Oncol ; 2018 Feb 22.

Article en En | MEDLINE | ID: mdl-29477660

Palabras clave

Clinical trial; Endometrial cancer; Molecular target; Serous

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Tipo de estudio: Clinical_trials / Guideline Idioma: En Revista: Gynecol Oncol Año: 2018 Tipo del documento: Article País de afiliación: Canadá

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google